Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

NIH: [Rituximab] Therapy for severe vasculitis shows long-term effectiveness

Discussion in 'Rituximab: News and Research' started by Firestormm, Aug 3, 2013.

  1. Firestormm

    Firestormm Guest

    Messages:
    5,823
    Likes:
    6,016
    Cornwall England
     
    SOC, Simon, biophile and 2 others like this.

See more popular forum discussions.

Share This Page